ADELAIDE, Australia, Dec. 16, 2021 /PRNewswire/ -- Bionomics Limited (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering in the United States (the Offering) of 1,622,000 American Depositary Shares (ADSs), each representing 180 ordinary shares of Bionomics, at an initial...